Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001698162 | SCV000527828 | likely benign | not provided | 2020-01-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001861566 | SCV002172847 | uncertain significance | Familial hemiplegic migraine | 2023-10-13 | criteria provided, single submitter | clinical testing | This sequence change affects codon 417 of the ATP1A2 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the ATP1A2 protein. This variant is present in population databases (rs142309356, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with ATP1A2-related conditions. ClinVar contains an entry for this variant (Variation ID: 386256). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |